oGVHD
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| 2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD (NCT04946721) | University of Maryland, Baltimore | 2022-04-27 |
| Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (NCT03591874) | Ocugen | 2018-12-23 |
| Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD) (NCT07210619) | Regenerative Ocular Immunobiologics LLC |
Track oGVHD automatically
Every clearance here is in the API, with alerts when new ones post.